Your search returned 48 studies. (Get alerts for new studies):
- Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
Conditions: Brain Tumors - Spinal Cord Tumors
6 Locations available
- A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
Conditions: Glioblastoma Multiforme - Glioma - Astrocytoma - Brain Tumor
1 Location available
- ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Mixed Gliomas
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Antineoplaston Therapy in Treating Patients With Residual or Recurrent Anaplastic Astrocytoma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Safety Study of Intracerebral Topotecan for Recurrent Brain Tumors
Conditions: Brain Neoplasms, Primary Malignant
1 Location available
- AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
Conditions: Brain and Central Nervous System Tumors
9 Locations available
- GDC-0449 in Treating Young Patients With Medulloblastoma That is Recurrent or Did Not Respond to Previous Treatment
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Recurrent Adult Brain Tumor
2 Locations available
- GDC-0449 in Treating Adult Patients With Recurrent or Refractory Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
6 Locations available
- Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma
Conditions: Adult Anaplastic Astrocytoma - Adult Anaplastic Oligodendroglioma - Adult Diffuse Astrocytoma - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Adult Oligodendroglioma - Recurrent Adult Brain Tumor
1 Location available
- A Phase I/II Study of the Photon Radiosurgery System
Conditions: Brain Tumor, Recurrent - Glioblastoma Multiforme
1 Location available
- Sorafenib and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
145 Locations available
- Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma, Intracranial Hemangiopericytoma, or Intracranial Hemangioblastoma
Conditions: Brain and Central Nervous System Tumors - Neurofibromatosis Type 1 - Neurofibromatosis Type 2 - Precancerous Condition
4 Locations available
- Prospective Study Differentiating Recurrent Brain Tumor Versus Radiation Injury Using Magnetic Resonance (MR) Spectroscopy, Diffusion Tensor Imaging a
Conditions: Radiation Injury - Brain Tumor
1 Location available
- Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
Conditions: Glioblastoma - Brain Tumor
2 Locations available
- RO4929097 in Treating Patients With Recurrent or Progressive Glioblastoma
Conditions: Brain and Central Nervous System Tumors
5 Locations available
- Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent, Progressive, or Newly Diagno
Conditions: Brain and Central Nervous System Tumors - Depression
1 Location available
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Neuroblastoma - Sarcoma
1 Location available
- Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors
Conditions: Glioma
1 Location available
- Enzastaurin and Carboplatin in Treating Patients With Recurrent or Refractory Primary Brain Tumors
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Everolimus in Treating Patients With Recurrent or Progressive Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- MLN8237 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Kidney Cancer - Leukemia - Liver Cancer - Neuroblastoma - Sarcoma
86 Locations available
- A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Re
Conditions: Adult Anaplastic Astrocytoma - Recurrent Grade III Glioma - Recurrent Grade IV Glioma - Adult Anaplastic Oligodendroglioma - Adult Brain Tumor - Adult Giant Cell Glioblastoma - Adult Glioblastoma - Adult Gliosarcoma - Adult Mixed Glioma - Recurrent Adult
1 Location available
- Carboplatin and Bevacizumab for Recurrent Ependymoma
Conditions: Brain Tumor - Spinal Tumor - Glial Tumour of Brain - Ependymal Tumour of Brain - Spinal Cord Ependymoma - Anaplastic Ependymoma
1 Location available
- More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
Conditions: Benign Neoplasms, Brain - Brain Cancer - Brain Neoplasms, Benign - Brain Neoplasms, Malignant - Brain Tumor, Primary - Brain Tumor, Recurrent - Brain Tumors - Intracranial Neoplasms - Neoplasms, Brain - Neoplasms, Intracranial - Primary Brain Neoplasms -
1 Location available
- Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Conditions: Brain and Central Nervous System Tumors
43 Locations available
- Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Conditions: Brain and Central Nervous System Tumors
2 Locations available
- Intracerebral Clysis in Treating Patients With Recurrent Primary Brain Tumors
Conditions: Recurrent Anaplastic Astrocytoma - Recurrent Anaplastic Oligodendroglioma - Recurrent Anaplastic Oligo-Astrocytoma - Recurrent Glioblastoma Multiforme
2 Locations available
- Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Temozolomide,Thiotepa and Carboplatin With Autologous Stem Cell Rescue Followed by 13-cis-retinoic Acid in Patients With Recurrent/Refractory Malignan
Conditions: Brain Tumors
21 Locations available
- Temozolomide in Treating Patients With Recurrent High-Grade Glioma
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
10 Locations available
- Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS P
Conditions: Brain and Central Nervous System Tumors
84 Locations available
- MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia
Conditions: Brain and Central Nervous System Tumors - Leukemia - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
22 Locations available
- GDC-0449 in Treating Younger Patients With Recurrent or Refractory Medulloblastoma
Conditions: Brain and Central Nervous System Tumors
11 Locations available
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
126 Locations available
- Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Conditions: Brain and Central Nervous System Tumors
1 Location available
- Cediranib Maleate and Cilengitide in Treating Patients With Progressive or Recurrent Glioblastoma
Conditions: Brain and Central Nervous System Tumors
10 Locations available
- High-Dose Methotrexate and Liposomal Cytarabine in Treating Patients With Central Nervous System (CNS) Metastases From Breast Cancer
Conditions: Stage IV Breast Cancer - Central Nervous System Involvement/Metastases - Leptomeningeal Metastases - Recurrent Breast Cancer - Tumors Metastatic to Brain
1 Location available
- Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytol
Conditions: Anaplastic Astrocytoma - Anaplastic Ependymoma - Anaplastic Meningioma - Anaplastic Oligodendroglioma - Brain Stem Glioma - Ependymoblastoma - Giant Cell Glioblastoma - Glioblastoma - Gliosarcoma - Grade III Meningioma - Meningeal Hemangiopericytoma - Mix
1 Location available
- MEK Inhibitor AZD6244 in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Conditions: Brain and Central Nervous System Tumors
8 Locations available
- Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
Conditions: Brain and Central Nervous System Tumors - Lymphoma - Lymphoproliferative Disorder - Small Intestine Cancer - Unspecified Childhood Solid Tumor, Protocol Specific
21 Locations available
- Study of a Retroviral Replicating Vector to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Conditions: Glioblastoma Multiforme - Anaplastic Astrocytoma - Anaplastic Oligodendroglioma - Anaplastic Oligoastrocytoma
3 Locations available
- Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glio
Conditions: Brain and Central Nervous System Tumors - Neurofibromatosis Type 1
20 Locations available
|